NCT07576725 clinical trial report covering Nivolumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600124258 clinical trial report covering Octreotide Acetate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261815 clinical trial report covering KAL-002, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600124305 clinical trial report covering Artenimol, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261695 clinical trial report covering SMP-656, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261831 clinical trial report covering HZ-A-018, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07578558 clinical trial report covering Nogapendekin alfa inbakicept-pmln, Phase 2, endpoints, sponsor, geography, readout timing and development white spa

NCT07578337 clinical trial report covering Botensilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07581210 clinical trial report covering QD202, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07578025 clinical trial report covering Zanzalintinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261564 clinical trial report covering Cough Granules, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07581821 clinical trial report covering Anlotinib Dihydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.